Synthesis of imidazolidin-4-one and 1H-imidazo[2,1-a]isoindole-2,5(3H,9bH)-dione derivatives of primaquine:: scope and limitations

被引:67
作者
Gomes, P
Araújo, MJ
Rodrigues, M
Vale, N
Azevedo, Z
Iley, J
Chambel, P
Morais, J
Moreira, R
机构
[1] Univ Porto, Ctr Invest Quim, Dept Quim, Fac Ciencias Porto, P-1467007 Oporto, Portugal
[2] Open Univ, Dept Chem, Milton Keynes MK7 6AA, Bucks, England
[3] Univ Lisbon, Fac Farm, Ctr Estudos Ciencias Farmaceut, P-1649019 Lisbon, Portugal
[4] Univ Lisbon, Fac Farm, UCTF, P-1649019 Lisbon, Portugal
关键词
antimalarial; imidazolidin-4-one; 1H-imidazo[2,1-a]isoindole-2,5(3H,9bH)-diones; malaria; primaquine; stereoselectivity;
D O I
10.1016/j.tet.2004.04.077
中图分类号
O62 [有机化学];
学科分类号
070303 [有机化学]; 081704 [应用化学];
摘要
The synthesis of imidazolidin-4-one derivatives of primaquine as potential antimalarial agents is described. The target compounds were synthesized in three steps: (i) condensation of (+/-)-primaquine with N-alpha-protected amino acids, (ii) removal of the N-alpha-protecting group, and (iii) reaction of the N-acylprimaquine with a carbonyl compound: acetone, three cyclic ketones and veratraldehyde. Using 2-formylbenzoic acid in the third step afforded 1H-imidazo[2,1-a]isoindole-2,5(3H,9bH)-diones. All products were isolated in good to excellent yields. Whereas imidazolidin-4-ones were formed as mixtures of all possible diastereomers in equal amounts, 1H-imidazo[2,1a]isoindole-2,5(3H,9bH)-diones were produced in a stereoselective fashion. The compounds hydrolyse very Slowly (t(1/2) 5-30 d) in pH 7.4 buffer to release primaquine. These primaquine derivatives are being submitted to biological assays, and preliminary results of their antimalarial activity are quite encouraging. (C) 2004 Elsevier Ltd. All rights reserved.
引用
收藏
页码:5551 / 5562
页数:12
相关论文
共 30 条
[1]
TERT-BUTYLOXYCARBONYLAMINO ACIDS AND THEIR USE IN PEPTIDE SYNTHESIS [J].
ANDERSON, GW ;
MCGREGOR, AC .
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 1957, 79 (23) :6180-6183
[2]
N-terminal 4-imidazolidinone prodrugs of Leu-enkephalin: synthesis, chemical and enzymatic stability studies [J].
Bak, A ;
Fich, M ;
Larsen, BD ;
Frokjaer, S ;
Friis, GJ .
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, 1999, 7 (04) :317-323
[3]
METABOLISM AND DISTRIBUTION OF PRIMAQUINE IN MONKEYS [J].
BAKER, JK ;
BEDFORD, JA ;
CLARK, AM ;
MCCHESNEY, JD .
PHARMACEUTICAL RESEARCH, 1984, (02) :98-100
[4]
BIODEGRADABLE MICROSPHERES .17. LYSOSOMAL DEGRADATION OF PRIMAQUINE-PEPTIDE SPACER ARMS [J].
BORISSOVA, R ;
STJARNKVIST, P ;
KARLSSON, MO ;
SJOHOLM, I .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1995, 84 (02) :256-262
[5]
ANTIMALARIAL ACTIVITY AND INHIBITION OF MONOAMINE OXIDASE-A AND OXIDASE-B BY EXO-ERYTHROCYTIC ANTIMALARIALS - OPTICAL ISOMERS OF PRIMAQUINE, N-ACYLATED CONGENERS, PRIMAQUINE METABOLITES AND 5-PHENOXY-SUBSTITUTED ANALOGS [J].
BROSSI, A ;
MILLET, P ;
LANDAU, I ;
BEMBENEK, ME ;
ABELL, CW .
FEBS LETTERS, 1987, 214 (02) :291-294
[6]
Brueckner RP, 2001, INFEC DIS S, P123
[7]
BUNDGAARD H, 1992, ADV DRUG DELIVER REV, V8, P1, DOI 10.1016/0169-409X(92)90014-H
[8]
Metabolism of primaquine by liver homogenate fractions -: Evidence for monoamine oxidase and cytochrome P450 involvement in the oxidative deamination of primaquine to carboxyprimaquine [J].
Constantino, L ;
Paixäo, P ;
Moreira, R ;
Portela, MJ ;
Do Rosario, VE ;
Iley, J .
EXPERIMENTAL AND TOXICOLOGIC PATHOLOGY, 1999, 51 (4-5) :299-303
[9]
USE OF NN'-ISOPROPYLIDENE DIPEPTIDES IN PEPTIDE-SYNTHESIS [J].
HARDY, PM ;
SAMWORTH, DJ .
JOURNAL OF THE CHEMICAL SOCIETY-PERKIN TRANSACTIONS 1, 1977, (17) :1954-1960
[10]
IZDEBSKI J, 1980, POL J CHEM, V54, P413